Blood draw for the laboratory assessment    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
303Usher syndrome1

303. Usher syndrome    [ 6 clinical trials,   11 drugs,   (DrugBank: 0),   0 drug target gene,   0 drug target pathway]
Searched query = "Usher syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 6 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02065011
(ClinicalTrials.gov)
September 12, 201314/2/2014A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1BAn Open-label Study to Determine the Long-term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1BUsher's SyndromeDrug: Blood draw for the laboratory assessmentSanofiNULLActive, not recruiting18 YearsN/AAll9Phase 1;Phase 2United States;France